Sun Pharma Advanced Research Company reports standalone net loss of Rs 71.05 crore in the March 2022 quarter

Sales decline 10.05% to Rs 25.24 crore

Net Loss of Sun Pharma Advanced Research Company reported to Rs 71.05 crore in the quarter ended March 2022 as against net loss of Rs 56.72 crore during the previous quarter ended March 2021. Sales declined 10.05% to Rs 25.24 crore in the quarter ended March 2022 as against Rs 28.06 crore during the previous quarter ended March 2021.

For the full year,net loss reported to Rs 203.40 crore in the year ended March 2022 as against net loss of Rs 151.14 crore during the previous year ended March 2021. Sales declined 45.74% to Rs 137.25 crore in the year ended March 2022 as against Rs 252.96 crore during the previous year ended March 2021.

ParticularsQuarter EndedYear EndedMar. 2022Mar. 2021% Var.Mar. 2022Mar. 2021% Var.Sales25.2428.06 -10 137.25252.96 -46 OPM %-263.63-179.72 --136.07-53.36 - PBDT-68.54-54.12 -27 -193.24-140.22 -38 PBT-71.05-56.72 -25 -203.40-151.14 -35 NP-71.05-56.72 -25 -203.40-151.14 -35

Powered by Capital Market - Live News